Literature DB >> 20733125

Response of histiocytoses to imatinib mesylate: fire to ashes.

Filip Janku1, Hesham M Amin, Dan Yang, Ignacio Garrido-Laguna, Jonathan C Trent, Razelle Kurzrock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20733125     DOI： 10.1200/JCO.2010.29.9073

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  16 in total

1.  Erdheim-Chester disease of the central nervous system: new manifestations of a rare disease.

Authors:  P Sedrak; L Ketonen; P Hou; N Guha-Thakurta; M D Williams; R Kurzrock; J M Debnam
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-29       Impact factor: 3.825

Review 2.  Erdheim-Chester Disease: a comprehensive review of the literature.

Authors:  Roei D Mazor; Mirra Manevich-Mazor; Yehuda Shoenfeld
Journal:  Orphanet J Rare Dis       Date:  2013-09-08       Impact factor: 4.123

3.  A tale of two histiocytic disorders.

Authors:  Filip Janku; Javier Munoz; Vivek Subbiah; Razelle Kurzrock
Journal:  Oncologist       Date:  2013-01-08

4.  New insights into the molecular pathogenesis of langerhans cell histiocytosis.

Authors:  Francesca M Rizzo; Mauro Cives; Valeria Simone; Franco Silvestris
Journal:  Oncologist       Date:  2014-01-16

5.  Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.

Authors:  Eli L Diamond; Lorenzo Dagna; David M Hyman; Giulio Cavalli; Filip Janku; Juvianee Estrada-Veras; Marina Ferrarini; Omar Abdel-Wahab; Mark L Heaney; Paul J Scheel; Nancy K Feeley; Elisabetta Ferrero; Kenneth L McClain; Augusto Vaglio; Thomas Colby; Laurent Arnaud; Julien Haroche
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

6.  The clinical spectrum of Erdheim-Chester disease: an observational cohort study.

Authors:  Juvianee I Estrada-Veras; Kevin J O'Brien; Louisa C Boyd; Rahul H Dave; Benjamin Durham; Liqiang Xi; Ashkan A Malayeri; Marcus Y Chen; Pamela J Gardner; Jhonell R Alvarado-Enriquez; Nikeith Shah; Omar Abdel-Wahab; Bernadette R Gochuico; Mark Raffeld; Elaine S Jaffe; William A Gahl
Journal:  Blood Adv       Date:  2017-02-14

7.  Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis.

Authors:  Filip Janku; Eli L Diamond; Aaron M Goodman; Vaijayanthi Kandadai Raghavan; Tamara G Barnes; Shumei Kato; Omar Abdel-Wahab; Benjamin H Durham; Funda Meric-Bernstam; Razelle Kurzrock
Journal:  Mol Cancer Ther       Date:  2019-04-23       Impact factor: 6.261

Review 8.  Erdheim-Chester disease.

Authors:  Julien Haroche; Laurent Arnaud; Fleur Cohen-Aubart; Baptiste Hervier; Frédéric Charlotte; Jean-François Emile; Zahir Amoura
Journal:  Curr Rheumatol Rep       Date:  2014-04       Impact factor: 4.592

Review 9.  Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net.

Authors:  Michael Girschikofsky; Maurizio Arico; Diego Castillo; Anthony Chu; Claus Doberauer; Joachim Fichter; Julien Haroche; Gregory A Kaltsas; Polyzois Makras; Angelo V Marzano; Mathilde de Menthon; Oliver Micke; Emanuela Passoni; Heinrich M Seegenschmiedt; Abdellatif Tazi; Kenneth L McClain
Journal:  Orphanet J Rare Dis       Date:  2013-05-14       Impact factor: 4.123

10.  BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease.

Authors:  Filip Janku; Cecile Rose T Vibat; Karena Kosco; Veronica R Holley; Goran Cabrilo; Funda Meric-Bernstam; Vanda M Stepanek; Patrick P Lin; Lorieta Leppin; Latifa Hassaine; Jason C Poole; Razelle Kurzrock; Mark G Erlander
Journal:  Oncotarget       Date:  2014-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.